Eve Health Group
- Short interest
- <0.01%
- 0.00 pp 30d
- as of 18 Aug 2020
- Reported shorts
- 19.3K
- Shares on issue
- 3.726B
Eve Health Group (EVE) Short Interest
Eve Health Group (ASX:EVE) had <0.01% of shares reported as short positions as of 18 Aug 2020, representing 19,334 shares. Eve Health Group operates in the Financial Services industry. Source: ASIC short position report (T+4 delay).
Source: official ASIC short position report, T+4 delay. Methodology · Disclaimer — not financial advice.
Price & short interest
Toggle series, zoom, and compare · ASIC daily, T+4About Eve Health Group
EVE Health Group operates as a vertically integrated producer of branded nutrition, health, and wellness products, focusing on developing and marketing its own brands within the health sector. The company aims to capitalize on increasing consumer demand for health-related products by targeting fast-growing markets. With a strategic global reach, EVE serves customers across Australia, New Zealand, Asia Pacific, and North America.
Company profile →Eve Health Group (ASX:EVE) has <0.01% of its shares on issue reported as short positions as of 18 Aug 2020, or about 19,334 shares. Over the past 30 days that figure has been broadly flat, and over 90 days it has been broadly flat. EVE is classified in the Financial Services industry. All figures come from official ASIC short position reports, published with a four trading-day (T+4) delay.
Short interest
History & FAQ →Weekly context: The 10 most shorted ASX stocks — Week 43, 2026.
Strategy fit
How each stock picker strategy reads EVE today
- Zanger BreakoutNot a candidate
- CAN SLIMNot a candidate
- Minervini Trend TemplateWatchScore 6rank 1594 of 1654
- Crowded-Short BreakoutNot a candidate
- Quality compoundersNot a candidate
Prices to 27 Oct 2026 · Mechanical readings of published rules, not recommendations · Not financial adviceFull strategy readings →
EVE fundamentals
In the year to 30 Jun 2026, Eve Health Group (ASX:EVE) recorded revenue of A$1.2M and a net loss after tax of A$1.9M. A year earlier it recorded revenue of A$1.7M and a net loss after tax of A$1.6M. Year-on-year growth: revenue −33.5% (FY). Net margin −164.0%, return on equity −50.4% (FY). Figures are in AUD, the company's reporting currency; source: Yahoo Finance, as at 14 Oct 2026.
Full statements, ratios and filings are on the Financials tab. Not financial advice.
Latest EVE news
All news- Change in substantial holding
asx · 27 Oct 2026
- Change of Director's Interest Notice
asx · 26 Oct 2026
- EVE Health Group (ASX:EVE) Under Pressure as Shares Touch a 52-Week Low - Kalkine
googlenews · 26 Oct 2026
Company details
website
address
More Financial Services Stocks
Other shorted stocks in this sector
Be the first to discuss EVE
Start a research thread or post the first pulse update